NUTEX HEALTH INC (NUTX) Stock Analyst Ratings
NASDAQ:NUTX - Nasdaq - US67079U3068 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to NUTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 197.54. This target is 60.73% above the current price.
NUTX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NUTX.
In the previous month the buy percentage consensus was at a similar level.
NUTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-20 | Maxim Group | Maintains | Buy -> Buy |
| 2025-05-15 | Benchmark | Maintains | Buy -> Buy |
| 2025-04-08 | Maxim Group | Maintains | Buy -> Buy |
| 2025-02-13 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-12 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-12 | Maxim Group | Maintains | Buy -> Buy |
| 2024-09-18 | Maxim Group | Initiate | Buy |
| 2024-08-21 | Benchmark | Maintains | Buy -> Buy |
| 2024-01-25 | Benchmark | Maintains | Buy -> Buy |
| 2023-11-14 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-29 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-17 | Benchmark | Maintains | Buy -> Buy |
| 2023-03-09 | Benchmark | Reiterate | Buy |
| 2022-12-23 | Benchmark | Initiate | Buy |